Stay Updated

Browse the Aminodex A–Z

Every published compound profile, organized alphabetically.

ABCDEFGHIJKLMNOPQRSTUVWXYZ

A

  • Abaloparatide Synthetic 34-amino-acid analog of parathyroid hormone-related protein (PTHrP 1-34); parathyroid hormone type 1 receptor (PTH1R) agonist; anabolic (bone-forming) osteoporosis agent
  • ACE-031 Recombinant soluble activin receptor type IIB fusion protein; ligand trap; myostatin/activin-pathway inhibitor
  • ACTH (1-39) Endogenous 39-amino-acid pituitary peptide hormone derived from pro-opiomelanocortin (POMC); melanocortin-2 receptor (MC2R) agonist with activity at other melanocortin receptors; adrenal steroidogenesis stimulator
  • Adamax Research-market synthetic peptide/peptidomimetic; purported modified Semax analogue; chemically incompletely standardized research compound
  • Adipotide Synthetic targeted proapoptotic peptidomimetic; adipose-vasculature-targeting experimental compound
  • AHK-Cu Synthetic copper(II)-binding tripeptide complex (Ala-His-Lys:Cu2+); structural relative of GHK-Cu; cosmetic and hair-care research ingredient
  • AICAR Synthetic adenosine analog (nucleoside, not a peptide); cell-permeable precursor of ZMP, an AMP mimetic; AMP-activated protein kinase (AMPK) activator
  • AOD-9604 Synthetic modified C-terminal human growth hormone fragment; experimental metabolic peptide
  • ARA-290 Synthetic 11-amino-acid erythropoietin-derived peptide; non-erythropoietic tissue-protective peptide; experimental innate-repair signaling agonist

B

  • B12 Essential water-soluble vitamin; cobalt-containing corrinoid cofactor; non-peptide micronutrient
  • B7-33 Synthetic single-chain peptide derived from the B-chain of human relaxin-2 (H2 relaxin); functionally selective (biased) agonist of relaxin family peptide receptor 1 (RXFP1)
  • BPC-157 Synthetic 15-amino-acid peptide; gastric pentadecapeptide derivative; investigational peptide
  • Bronchogen Synthetic tetrapeptide; short peptide bioregulator; experimental bronchial/respiratory epithelial-associated peptide

C

  • Cagrilintide Long-acting acylated amylin analogue; amylin and calcitonin receptor agonist
  • Cardiogen Synthetic tetrapeptide; short peptide bioregulator; experimental cardiac-associated peptide
  • Cartalax Synthetic tripeptide; short peptide bioregulator; experimental cartilage/bone-associated peptide
  • Cerebrolysin Porcine brain-derived peptide preparation; low-molecular-weight peptide mixture; neurotrophic drug preparation
  • Chonluten Synthetic tripeptide; short peptide bioregulator; experimental immunomodulatory/bronchial-associated peptide
  • CJC-1295 Synthetic growth hormone-releasing hormone (GHRH/GRF) analogue; long-acting growth hormone secretagogue
  • CJC-1295 (no DAC) Synthetic tetrasubstituted GHRH(1-29) analogue; short-acting experimental GHRH analogue
  • Cortagen Synthetic tetrapeptide; short peptide bioregulator; experimental neuroregulatory peptide
  • Crystagen Synthetic tripeptide; short peptide bioregulator; experimental immune-associated peptide

D

  • Delta Sleep-Inducing Peptide Synthetic nonapeptide; experimental neuropeptide; sleep/stress-regulation research peptide
  • Dermorphin Naturally occurring amphibian heptapeptide containing a D-amino acid; potent, selective mu-opioid receptor agonist
  • Dihexa Synthetic angiotensin IV-derived peptidomimetic; HGF/c-Met modulator; experimental neurotrophic small molecule
  • Dulaglutide Long-acting glucagon-like peptide-1 (GLP-1) receptor agonist; recombinant fusion protein of two GLP-1 analog chains linked to a modified human IgG4 Fc fragment; once-weekly incretin therapy

E

  • Eloralintide Long-acting selective amylin receptor agonist; preferential AMY1 receptor agonist
  • Epitalon Synthetic tetrapeptide; pineal-derived peptide bioregulator; experimental geroprotective peptide
  • EPO (Erythropoietin) Endogenous 165-amino-acid glycoprotein hormone (cytokine) produced mainly by the kidney; erythropoietin receptor (EPOR) agonist; erythropoiesis-stimulating agent (ESA)

F

  • Follistatin-344 Endogenous follistatin precursor isoform; activin-binding protein; myostatin-pathway antagonist
  • FOXO4 Endogenous intracellular transcription factor of the forkhead box O (FOXO) family (about 500 amino acids); downstream target of PI3K-Akt signaling; regulator of stress resistance, cell-cycle arrest, apoptosis and senescence
  • FOXO4-DRI Synthetic D-retro-inverso peptide; FOXO4-p53 protein-interaction inhibitor; experimental senolytic peptide

G

  • GDF-8 (Myostatin) Endogenous secreted signaling protein of the TGF-β superfamily; negative regulator of skeletal muscle mass; activin type II receptor (ActRIIB/ActRIIA) ligand
  • GHK (Copper-Free) Naturally occurring human tripeptide (Gly-His-Lys); high-affinity copper(II)-binding peptide; matrix-remodeling and gene-expression modulator studied mainly in cell and animal models
  • GHK-CU Naturally occurring copper-binding tripeptide complex; metallopeptide; extracellular-matrix and tissue-remodeling research compound. GHK consists of three amino acids—glycine, histidine, and lysine—and can bind a copper(II) ion to form GHK-Cu.
  • GLOW Blend Multi-compound research blend; non-standardized commercial peptide mixture
  • Glutathione Endogenous tripeptide; intracellular thiol antioxidant; redox regulator; detoxification substrate
  • Gonadorelin Synthetic gonadotropin-releasing hormone; GnRH receptor agonist; hypothalamic reproductive hormone
  • Growth Hormone-Releasing Peptide-2 Synthetic hexapeptide; growth hormone secretagogue; ghrelin/growth hormone secretagogue receptor agonist
  • Growth Hormone-Releasing Peptide-6 Synthetic hexapeptide; growth hormone secretagogue; ghrelin/growth hormone secretagogue receptor agonist

H

  • HCG (Human Chorionic Gonadotropin) Glycoprotein hormone; luteinizing-hormone receptor agonist; gonadotropin
  • Hexarelin Synthetic hexapeptide; growth hormone secretagogue; ghrelin/growth hormone secretagogue receptor agonist
  • HGH (Somatropin) Endogenous 191-amino-acid, 22-kDa pituitary polypeptide hormone; growth hormone receptor (GHR) agonist; approved recombinant hormone therapy
  • HGH Fragment 176-191 Synthetic C-terminal human growth hormone-derived peptide fragment; experimental metabolic peptide
  • HMG (Human Menopausal Gonadotropin) Urine-derived gonadotropin preparation from postmenopausal women containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity; FSH and LH/hCG receptor agonist; fertility (ovarian stimulation) medicine
  • Humanin Mitochondrial-derived peptide (MDP); endogenous cytoprotective micropeptide associated with the mitochondrial 16S rRNA (MT-RNR2) region

I

  • IGF-1 DES Naturally occurring truncated variant of insulin-like growth factor 1 lacking the N-terminal tripeptide Gly-Pro-Glu (67 amino acids); IGF-1 receptor agonist with markedly reduced IGF-binding-protein affinity
  • IGF-1 LR3 Engineered recombinant insulin-like growth factor-1 analogue; IGF-1 receptor agonist; reduced IGF-binding-protein-affinity analogue
  • Ipamorelin Synthetic pentapeptide; growth hormone secretagogue; ghrelin receptor / growth hormone secretagogue receptor agonist

K

  • Kisspeptin-10 Endogenous kisspeptin fragment; KISS1R/GPR54 agonist; reproductive neuroendocrine peptide
  • KPV Naturally occurring tripeptide; C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH); melanocortin-derived peptide investigated for anti-inflammatory activity

L

  • L-Carnitine Endogenous quaternary ammonium compound; mitochondrial fatty-acid transport cofactor; conditionally essential nutrient
  • Lemon Bottle Multi-ingredient commercial formulation; cosmetic/lipolysis-market product; non-peptide formulation
  • Lipo-C Non-standardized multi-ingredient lipotropic formulation; nutrient/amino-acid blend; non-peptide formulation
  • Liraglutide Long-acting acylated glucagon-like peptide-1 receptor (GLP-1R) agonist; GLP-1 analogue
  • Livagen Synthetic tetrapeptide; short peptide bioregulator; experimental liver-associated peptide
  • LL-37 Human cathelicidin antimicrobial peptide; cationic host-defense peptide; innate immune peptide

M

  • Matrixyl Synthetic palmitoylated pentapeptide; lipopeptide; matrikine-derived cosmetic signal peptide
  • Mazdutide Long-acting peptide dual agonist of the glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR)
  • Melanotan 1 Synthetic α-melanocyte-stimulating hormone analogue; melanocortin-1 receptor agonist; melanocortin peptide
  • Melanotan 2 Synthetic cyclic α-melanocyte-stimulating hormone analogue; nonselective melanocortin receptor agonist
  • MGF (Mechano Growth Factor) Splice variant of the insulin-like growth factor 1 (IGF1) gene and its 24-amino-acid C-terminal E-domain peptide; proposed local (autocrine/paracrine) muscle-repair signal; receptor not identified
  • MOTS-c Mitochondrial-derived peptide (MDP); 16-amino-acid peptide encoded within mitochondrial DNA

N

O

  • Orexin-A Endogenous 33-amino-acid hypothalamic neuropeptide; prepro-orexin (HCRT gene) product; dual orexin-receptor (OX1R/OX2R) agonist neuropeptide
  • Orexin-B Endogenous 28-amino-acid linear hypothalamic neuropeptide; prepro-orexin (HCRT gene) product; orexin receptor 2 (OX2R)-preferring agonist neuropeptide
  • Orforglipron Synthetic small-molecule (non-peptide) oral GLP-1 receptor agonist; partial, G protein-biased GLP-1R agonist; anti-obesity and antidiabetic agent
  • Ovagen Synthetic tripeptide; short peptide bioregulator; experimental renal-associated peptide
  • Oxytocin Endogenous cyclic nonapeptide hormone; neuropeptide; oxytocin-receptor agonist

P

  • P21 (P021) Synthetic adamantane-modified short peptidomimetic derived from ciliary neurotrophic factor (CNTF); experimental neurogenic/neurotrophic compound
  • Pancragen Synthetic tetrapeptide; insulinotropic-peptide mimetic; experimental pancreatic/endocrine bioregulator
  • PE-22-28 Synthetic heptapeptide; spadin-derived TREK-1 potassium-channel inhibitor; experimental antidepressant peptide
  • PEG-MGF PEGylated synthetic peptide based on the E-domain region associated with an IGF-1 splice variant; experimental research peptide
  • Petrelintide Long-acting amylin analogue; investigational amylin receptor agonist
  • Pinealon Synthetic tripeptide; short peptide bioregulator; experimental neuroprotective peptide
  • PNC-27 Synthetic 32-residue chimeric peptide (p53 residues 12–26 fused to a penetratin cell-penetrating sequence); experimental membrane-active anticancer peptide
  • Pramlintide Synthetic amylin analogue; amylin receptor agonist; pancreatic hormone analogue
  • Prostamax Synthetic tetrapeptide; short peptide bioregulator; experimental prostate-associated peptide
  • PT-141 Synthetic cyclic melanocortin peptide; melanocortin receptor agonist; centrally acting sexual-function drug
  • PTD-DBM Synthetic cell-penetrating competitor peptide; inhibitor of the CXXC5–Dishevelled interaction; experimental Wnt/β-catenin pathway activator

R

  • Retatrutide Long-acting single-peptide triple agonist of the GIP, GLP-1, and glucagon receptors; investigational metabolic peptide

S

  • Selank Synthetic heptapeptide; tuftsin analogue; glyproline peptide; experimental anxiolytic/neuropeptide
  • Semaglutide Long-acting glucagon-like peptide-1 receptor (GLP-1R) agonist; acylated GLP-1 analogue
  • Semax Synthetic heptapeptide; ACTH(4-7) analogue; melanocortin-derived neuropeptide; experimental neuroprotective/nootropic peptide
  • Sermorelin Synthetic 29-amino-acid growth hormone-releasing hormone fragment; GHRH receptor agonist; growth-hormone secretagogue
  • SLU-PP-332 Synthetic small-molecule estrogen-related receptor pan-agonist; ERRα/β/γ agonist; experimental exercise-mimetic compound
  • SNAP-8 Synthetic acetylated, amidated octapeptide; SNAP-25-mimetic cosmetic peptide; topical "neurotransmitter-modulating" anti-wrinkle ingredient
  • SS-31 Mitochondria-targeting aromatic-cationic tetrapeptide; mitochondrial cardiolipin-binding peptide
  • Survodutide Long-acting acylated peptide; dual glucagon receptor (GCGR) and GLP-1 receptor (GLP-1R) agonist

T

  • TB-500 Synthetic peptide fragment derived from Thymosin Beta-4; investigational research peptide
  • Teriparatide Recombinant 34-amino-acid N-terminal fragment of human parathyroid hormone; PTH1 receptor agonist; bone-forming (anabolic) osteoporosis drug
  • Tesamorelin Synthetic growth hormone-releasing hormone (GHRH/GHRF) analogue; growth hormone secretagogue
  • Testagen Research-market short peptide bioregulator; purported testicular/reproductive-associated tetrapeptide
  • Thymalin Polypeptide extract from calf (bovine) thymus; Khavinson-school peptide bioregulator; immunomodulator registered in Russia
  • Thymogen Synthetic dipeptide (L-glutamyl-L-tryptophan); Khavinson-school peptide bioregulator; immunomodulator registered in Russia
  • Thymosin Alpha-1 28-amino-acid thymic peptide; immunomodulatory peptide; synthetic analogue of endogenous thymosin alpha-1
  • Thymosin Beta-4 Endogenous 43-amino-acid actin-binding peptide; beta-thymosin family peptide; regenerative and cytoskeletal regulatory peptide
  • Thymulin Endogenous zinc-dependent thymic nonapeptide hormone; thymic epithelial cell product; immunomodulatory and neuroendocrine-active peptide
  • Tirzepatide Long-acting single-peptide dual agonist of the glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R)
  • Triptorelin Synthetic decapeptide gonadotropin-releasing hormone (GnRH/LHRH) agonist analog; hormonal therapy agent

V

  • Vesilute Synthetic dipeptide (L-glutamyl-L-aspartate); Khavinson-school "ultrashort" peptide bioregulator; marketed as a urinary-system (bladder) regulator
  • Vesugen Synthetic tripeptide; short peptide bioregulator; experimental vascular/endothelial regulatory peptide
  • Vilon Synthetic dipeptide; short peptide bioregulator; experimental thymic/immunoregulatory peptide
  • VIP (Vasoactive Intestinal Peptide) Endogenous 28-amino-acid neuropeptide of the secretin/glucagon family; VPAC1/VPAC2 receptor agonist; neurotransmitter, vasodilator and immunomodulatory peptide